Ophthalmic and Otic Disorders Pharmacology
Ophthalmic Anti-Infectives: Mechanism and Properties
- Ophthalmic anti-infectives are pharmacological agents used to treat ocular infections and can be classified based on their action as either bacteriostatic (inhibiting growth) or bactericidal (killing bacteria).
- Pharmacokinetics: These medications generally penetrate only the ocular fluid and tissues. There is minimal systemic absorption associated with these topical applications.
- Precautions: Providers must use caution because these agents can trigger hypersensitivity reactions.
Adverse Drug Reactions (ADRs) and Specific Ophthalmic Agents
- General ADR: The most common adverse reaction to ophthalmic anti-infectives is local irritation.
- Super Infection: Prolonged use of these medications can lead to a super infection.
- Bacitracin: Specifically known to cause blurred vision.
- Aminoglycosides: Use can lead to localized ocular toxicity.
- Fluoroquinolones: These may cause a white crystalline precipitate to form in the superficial portion of the cornea.
- Reference Materials: Students are directed to study the following in their textbook:
- Table 26−1: Lists ophthalmic anti-infectives, drug interactions, possible effects, and clinical implications.
- Table 26−3: Discusses indications, forms, doses, and specific comments regarding each anti-infective ophthalmic medication.
Clinical Indications for Ophthalmic Anti-Infectives
- Chlamydia Conjunctivitis in Newborns:
- Shortly after birth, newborns typically receive Erythromycin eye ointment in both eyes to prevent Chlamydial conjunctivitis, which can lead to blindness.
- If a newborn develops the infection, it is treated with systemic Erythromycin.
- Bacterial Conjunctivitis:
- Presentation: Symptoms include erythema, purulent discharge, itching, burning, and matted eyelashes (often referred to as "mad eyelashes").
- Demographics: While it can affect any individual of any age, it is more common in children between the ages of 3 months and 8 years.
- Treatment: Typically managed with topical ophthalmic anti-infective medications.
- Blepharitis:
- Defined as acute or chronic inflammation of the eyelash follicles and the meibomian glands of the eyelids.
- Treatment Protocol: Instruct the patient to scrub eyelashes with a gentle "no-tear" soap to clear follicles and glands. Treatment may also include Erythromycin ophthalmic ointment.
- Hordeolums (Styes):
- These are treated with antibiotic eye drops or ointments.
- Viral Conjunctivitis:
- Anti-infectives may be used if indicated; however, if Herpes is suspected, the patient must be referred immediately to an ophthalmologist.
Patient Education for Ophthalmic Anti-Infectives
- Administration Techniques:
- Prevent contamination by not touching the eye dropper to the eye.
- Wash hands thoroughly both before and after administration.
- Proper instruction on how to instill drops or ointment.
- Lifestyle and Hygiene Management:
- Do not share towels.
- Avoid using eye makeup while the infection is being treated.
- Clear purulent discharge using a wet cotton ball or a warm washcloth.
- Apply warm compresses to the affected eye.
Ocular Anti-Allergic Drugs: Mast Cell Stabilizers and Antihistamines
- Mast Cell Stabilizers: These limit hypersensitivity reactions by inhibiting the degranulation of sensitized mast cells. They are typically used to treat vernal conjunctivitis.
- Antihistamines: These work by blocking the Histamine 1 (H1) receptors. They are typically used to treat allergic conjunctivitis.
- Precautions:
- Can cause hypersensitivity reactions.
- Products containing Benzalkonium chloride can affect soft contact lenses. Patients wearing contacts must be informed.
- Common ADRs:
- Stinging and burning upon instillation (most common).
- Blurred vision, discomfort, or tearing.
- Drug Interactions: Mast cell stabilizers and ocular antihistamines typically have no known drug interactions.
Ophthalmic Anti-Inflammatory Agents
- Classes: Available as Ophthalmic NSAIDs and Ophthalmic Corticosteroid agents.
- Ocular Corticosteroids Specialist Referral: Any patient requiring ocular corticosteroids must be referred to an ophthalmologist due to severe risks.
- Naphazoline (Nefazoline): An anti-inflammatory ocular agent that may precipitate narrow-angle glaucoma.
- Risks of Ocular Corticosteroids:
- Glaucoma (elevated intraocular pressure, optic nerve damage).
- Loss of visual acuity and visual field defects.
- Cataract formation.
- Secondary eye infections or exacerbation of existing infections.
- Perforation of the globe.
Ocular Lubricants and Vasoconstrictors
- Ocular Lubricants (Artificial Tears):
- Used for relief of dry eyes and irritation.
- Typical usage is 3−4 times per day.
- Warning: Overuse (exceeding a maximum of 4 times a day) can actually exacerbate dry eye symptoms.
- Ophthalmic Vasoconstrictors:
- Used for temporary relief of redness caused by minor irritants or allergic conjunctivitis.
- Brands: Bausch & Lomb Allergy Drops, Clear Eyes, Comfort Eye Drops.
- Contraindication: Narrow-angle glaucoma.
- Dosing (Adults): 1−2 drops up to a maximum of 4 times daily. Not recommended for children.
- Overuse Warning: Prolonged use can lead to dry eye syndrome.
- Drug Interactions:
- Naphazoline interacts with Tricyclic Antidepressants.
- All ophthalmic vasoconstrictors interact with Monoamine Oxidase Inhibitors (MAOIs) and Beta Blockers.
Fluorescein Eye Stain Procedure
- Purpose: Used to detect corneal abrasions.
- Definition: Topical Fluorescein Sodium is a yellow, water-soluble, dibasic acidic xanthine dye.
- Procedure:
1. Instill 1 or 2 drops of fluorescein solution or use strips moistened with sterile water.
2. Have the patient roll their eyes to coat the surface.
3. Darken the exam room.
4. Use a Woods Lamp (UV light) to examine the eye.
- Results: Corneal abrasions will glow a bright neon yellow-green. An intact cornea will not stain, though it may show slight yellow discoloration.
Otic Anti-Infectives and Analgesics
- Combination Products: Medications containing both a corticosteroid and an antibiotic (e.g., Cortisporin, CiproDex, Cipro HC).
- The hydrocortisone (HC) component reduces inflammation in the ear canal.
- Primary use: Otitis externa (external ear infection).
- Contraindication: Do not use any medication with a steroid component if the tympanic membrane is perforated.
- Antibiotic-only Drops: Gentamicin and Ofloxacin.
- Otitis Externa Adjuncts: Acid or alcohol drops can be used to dry moisture in the ear canal.
- Topical Otic Analgesics:
- Agents: Auralgan and Benzocaine.
- Usage: Provide pain relief for Otitis Media.
- Dosing: Instill into the affected ear 3−4 times a day or as often as every 1−2 hours as needed for pain.
Management of Impacted Cerumen
- Medications: Carbamide peroxide-based products such as Debrox, Dent's Ear Wax, and Murine Ear Wax Removal.
- Clinical Application: Used to soften earwax prior to irrigation.
- Clinical Timing: The medication should sit in the ear for at least 15−20 minutes before irrigation to ensure the wax is soft enough to remove.
- Home Administration:
- Instill 1−5 drops (depending on canal size) twice daily for up to 4 days.
- Persistent cases: If wax is too hard to remove in-office, patients are sent home with a prescription to use for 4 days before returning for irrigation.